Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC90B antisense RNA 1 (CCDC90B-AS1) is a long non-coding RNA (lncRNA) transcribed in the antisense direction relative to the protein-coding CCDC90B gene[1][4]. Antisense RNAs like CCDC90B-AS1 generally function to regulate gene expression at multiple levels, including chromatin modification, transcription, and RNA stability, often affecting the expression of their corresponding sense (protein-coding) gene or neighboring genes, usually in a gene- or context-specific manner[2][3][8]. No specific biological or disease roles, drug interactions, or biomarker applications have yet been described for CCDC90B-AS1 itself[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCDC90B antisense RNA 1 (CCDC90B-AS1).